Literature DB >> 17127396

Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women.

Robert Duncan1, Paul Shapshak, J Bryan Page, Francesco Chiappelli, Clyde B McCoy, Sarah E Messiah.   

Abstract

This study reports on the role of cocaine as effect modifier of the association of CD4+ cell counts and RNA viral load. HIV-1 seropositive (n = 80) and seronegative (n = 42) African American women (AAW) crack cocaine smokers were recruited. Increasing cocaine use, based on self-reports and laboratory values, significantly exacerbates the immunopathology of HIV-1 in a dose-response manner, confirmed by a non-linear drop in CD4+ cell number for a given viral load in HIV+ AAW. This report supports a view of deleterious effects due to cocaine use in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127396     DOI: 10.2741/2162

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  18 in total

Review 1.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

2.  Substance use patterns and HIV-1 RNA viral load rebound among HIV-positive illicit drug users in a Canadian setting.

Authors:  Farah Ladak; Eugenia Socias; Seonaid Nolan; Huiru Dong; Thomas Kerr; Evan Wood; Julio Montaner; M-J Milloy
Journal:  Antivir Ther       Date:  2019

Review 3.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

Review 4.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

5.  Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment.

Authors:  Ashley E Burch; Carla J Rash; Nancy M Petry
Journal:  J Subst Abuse Treat       Date:  2017-03-09

6.  Cocaine enhances HIV-1-induced CD4(+) T-cell apoptosis: implications in disease progression in cocaine-abusing HIV-1 patients.

Authors:  Jui Pandhare; Amma B Addai; Chinmay K Mantri; Cynthia Hager; Rita M Smith; Louis Barnett; Fernando Villalta; Spyros A Kalams; Chandravanu Dash
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

7.  Longitudinal Modeling of Depressive Trajectories Among HIV-Infected Men Using Cocaine.

Authors:  Shibani Mukerji; Roxanna Haghighat; Vikas Misra; David R Lorenz; Alex Holman; Anupriya Dutta; Dana Gabuzda
Journal:  AIDS Behav       Date:  2017-07

Review 8.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

9.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.